From July 1, 2022 to September 30, 2022, the company has repurchased 7,201,500 shares, representing 0.63% for CNY 102.22 million. With this, the company has completed the repurchase of 10,633,664 shares, representing 0.92% for CNY 151.61 million under the buyback announced on May 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.95 CNY | -0.29% | -3.66% | -7.86% |
05-23 | Aodong Medicine Industry's Unit Gets Certificates for 10 Traditional Chinese Medicines | MT |
05-20 | Jilin Aodong Pharmaceutical Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.86% | 2.3B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.83% | 248B | |
-2.00% | 219B | |
+10.99% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.